Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Fulcrand

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Al-Maghrib Al-Tibbi. Maroc Medical|December 1, 1979
[Etiologic diagnosis and prognosis of 42 cases of acute renal insufficiency hospitalized in medical intensive care units 1976-1977]L Balafrej, G Fulcrand, J Bensouda, et al.
Annales De L'Institut Pasteur De Lille|January 1, 1971
[Salmonella dublin infections]J Demarchi, G Fulcrand, A Bennani, et al.
Biochemistry|May 7, 1996
Carboranyl oligonucleotides. 3. Biochemical properties of oligonucleotides containing 5-(o-carboranyl-1-yl)-2'-deoxyuridineZ J Lesnikowski, G Fulcrand, R M Lloyd, et al.
Journal of Pharmaceutical Sciences|December 1, 1994
Pharmacokinetics of 5-carboranyl-2'-deoxyuridine in ratsV R Jarugula, R F Schinazi, G Fulcrand, et al.
International Journal of Radiation Oncology, Biology, Physics|March 30, 1994
Cellular pharmacology and biological activity of 5-carboranyl-2'-deoxyuridineR F Schinazi, N M Goudgaon, G Fulcrand, et al.
Journal of Medicinal Chemistry|August 5, 1994
Synthesis and biological properties of 5-o-carboranyl-1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)uracilG Fulcrand-el Kattan, N M Goudgaon, N Ilksoy, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Al-Maghrib Al-Tibbi. Maroc Medical|December 1, 1979
[Etiologic diagnosis and prognosis of 42 cases of acute renal insufficiency hospitalized in medical intensive care units 1976-1977]L Balafrej, G Fulcrand, J Bensouda, et al.
Annales De L'Institut Pasteur De Lille|January 1, 1971
[Salmonella dublin infections]J Demarchi, G Fulcrand, A Bennani, et al.
Biochemistry|May 7, 1996
Carboranyl oligonucleotides. 3. Biochemical properties of oligonucleotides containing 5-(o-carboranyl-1-yl)-2'-deoxyuridineZ J Lesnikowski, G Fulcrand, R M Lloyd, et al.
Journal of Pharmaceutical Sciences|December 1, 1994
Pharmacokinetics of 5-carboranyl-2'-deoxyuridine in ratsV R Jarugula, R F Schinazi, G Fulcrand, et al.
International Journal of Radiation Oncology, Biology, Physics|March 30, 1994
Cellular pharmacology and biological activity of 5-carboranyl-2'-deoxyuridineR F Schinazi, N M Goudgaon, G Fulcrand, et al.
Journal of Medicinal Chemistry|August 5, 1994
Synthesis and biological properties of 5-o-carboranyl-1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)uracilG Fulcrand-el Kattan, N M Goudgaon, N Ilksoy, et al.
Pageof 1